Article Information
History
- January 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lavanya Sivapalan1,
- Graeme Thorn1,
- Emanuela Gadaleta1,
- Hemant Kocher2,
- Helen Ross-Adams1 and
- Claude Chelala1,*
- 1Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, UK, EC1M 6BQ
- 2Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, UK, EC1M 6BQ
- ↵*Corresponding Author: Prof C Chelala, c.chelala{at}qmul.ac.uk